(VIANEWS) – Apollo Commercial Real Estate Finance (ARI), Zoetis (ZTS), Lexington Realty Trust (LXP) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Apollo Commercial Real Estate Finance (ARI)
27% sales growth and 13% return on equity
Apollo Commercial Real Estate Finance, Inc. operates as a real estate investment trust (REIT) that primarily originates, acquires, invests in, and manages commercial first mortgage loans, subordinate financings, and other commercial real estate-related debt investments in the United States. It is qualified as a REIT under the Internal Revenue Code. As a REIT, it would not be subject to federal income taxes, if the company distributes at least 90% of its REIT taxable income to its stockholders. Apollo Commercial Real Estate Finance, Inc. was founded in 2009 and is based in New York, New York.
Earnings Per Share
As for profitability, Apollo Commercial Real Estate Finance has a trailing twelve months EPS of $1.92.
PE Ratio
Apollo Commercial Real Estate Finance has a trailing twelve months price to earnings ratio of 5.99. Meaning, the purchaser of the share is investing $5.99 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 81.5%, now sitting on 358.42M for the twelve trailing months.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 28, 2023, the estimated forward annual dividend rate is 1.4 and the estimated forward annual dividend yield is 12.18%.
Moving Average
Apollo Commercial Real Estate Finance’s value is above its 50-day moving average of $11.02 and higher than its 200-day moving average of $10.82.
Yearly Top and Bottom Value
Apollo Commercial Real Estate Finance’s stock is valued at $11.51 at 11:22 EST, way under its 52-week high of $13.10 and way higher than its 52-week low of $7.91.
2. Zoetis (ZTS)
10.1% sales growth and 48.02% return on equity
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Earnings Per Share
As for profitability, Zoetis has a trailing twelve months EPS of $4.41.
PE Ratio
Zoetis has a trailing twelve months price to earnings ratio of 43.19. Meaning, the purchaser of the share is investing $43.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.02%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jul 19, 2023, the estimated forward annual dividend rate is 1.5 and the estimated forward annual dividend yield is 0.79%.
Volume
Today’s last reported volume for Zoetis is 584934 which is 71.91% below its average volume of 2083030.
Moving Average
Zoetis’s worth is above its 50-day moving average of $174.75 and way higher than its 200-day moving average of $165.10.
Previous days news about Zoetis(ZTS)
- According to Zacks on Thursday, 10 August, "Investors interested in stocks from the Medical – Drugs sector have probably already heard of USANA Health Sciences (USNA Quick QuoteUSNA – Free Report) and Zoetis (ZTS Quick QuoteZTS – Free Report) . ", "Currently, USANA Health Sciences has a Zacks Rank of #1 (Strong Buy), while Zoetis has a Zacks Rank of #3 (Hold). "
3. Lexington Realty Trust (LXP)
8% sales growth and 4.98% return on equity
Lexington Realty Trust (NYSE: LXP) is a publicly traded real estate investment trust (REIT) that owns a diversified portfolio of real estate assets consisting primarily of equity investments in single-tenant net-leased commercial properties across the United States. Lexington seeks to expand its industrial portfolio through build-to-suit transactions, sale-leaseback transactions and other transactions, including acquisitions.
Earnings Per Share
As for profitability, Lexington Realty Trust has a trailing twelve months EPS of $0.38.
PE Ratio
Lexington Realty Trust has a trailing twelve months price to earnings ratio of 27.11. Meaning, the purchaser of the share is investing $27.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.98%.
Volume
Today’s last reported volume for Lexington Realty Trust is 1311760 which is 40.86% below its average volume of 2218420.
Sales Growth
Lexington Realty Trust’s sales growth is 7.3% for the ongoing quarter and 8% for the next.
Moving Average
Lexington Realty Trust’s worth is above its 50-day moving average of $10.17 and higher than its 200-day moving average of $10.23.
Yearly Top and Bottom Value
Lexington Realty Trust’s stock is valued at $10.30 at 11:22 EST, way under its 52-week high of $11.92 and way higher than its 52-week low of $8.81.
4. Roper Industries (ROP)
7.7% sales growth and 7.68% return on equity
Roper Technologies, Inc. designs and develops software, and technology enabled products and solutions. The company offers management, campus solutions, diagnostic and laboratory information management, enterprise management, information solutions, transportation management, financial and compliance management, and cloud-based financial analytics and performance management software; cloud-based software to the property and casualty insurance industry; and software, services, and technologies for foodservice operations. It also provides cloud-based data, collaboration, and estimating automation software; electronic marketplace; visual effects and 3D content software; wireless sensor network and solutions; cloud-based software for the life insurance and financial services industries; supply chain software; health care service and software; RFID card readers; data analytics and information; and pharmacy software solutions. In addition, the company offers ultrasound accessories; dispensers and metering pumps; automated surgical scrub and linen dispensing equipment; water meters; optical and electromagnetic measurement systems; and medical devices. It distributes and sells its products through direct sales, manufacturers' representatives, resellers, and distributors. The company was formerly known as Roper Industries, Inc. and changed its name to Roper Technologies, Inc. in April 2015. The company was incorporated in 1981 and is based in Sarasota, Florida.
Earnings Per Share
As for profitability, Roper Industries has a trailing twelve months EPS of $10.91.
PE Ratio
Roper Industries has a trailing twelve months price to earnings ratio of 44.72. Meaning, the purchaser of the share is investing $44.72 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.68%.
5. Huron Consulting Group (HURN)
5.8% sales growth and 12.95% return on equity
Huron Consulting Group Inc., a professional services firm, provides consultancy services in the United States and internationally. Its Healthcare segment provides advisory services in the areas of financial and operational improvement, care transformation, and revenue cycle managed services; organizational transformation; and digital, technology and analytic solutions to national and regional hospitals, integrated health systems, academic medical centers, community hospitals, and medical groups. The company's Business Advisory segment offers cloud-based technology, analytics, restructuring, and capital advisory solutions to life science, financial, healthcare, education, energy and utilities, and industrials and manufacturing industries, as well as to public sectors. Its Education segment provides research enterprise and student lifecycle; digital, technology and analytic solutions; and organizational transformation services to public and private colleges and universities, academic medical centers, research institutes, and other not-for-profit organizations. Huron Consulting Group Inc. was incorporated in 2002 and is headquartered in Chicago, Illinois.
Earnings Per Share
As for profitability, Huron Consulting Group has a trailing twelve months EPS of $2.96.
PE Ratio
Huron Consulting Group has a trailing twelve months price to earnings ratio of 33.6. Meaning, the purchaser of the share is investing $33.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.95%.
Volume
Today’s last reported volume for Huron Consulting Group is 103777 which is 19.63% below its average volume of 129129.
Yearly Top and Bottom Value
Huron Consulting Group’s stock is valued at $99.47 at 11:22 EST, under its 52-week high of $104.56 and way higher than its 52-week low of $64.05.
